FDA Panel Will Hear Proponents and Opponents of Uterine Device at Hearing

Proponents of a surgical tool used for a common uterine procedure will argue at a hearing next month that the device's benefits—facilitating a less-invasive operation—make it too important to take it off the market.

But opponents say the device's cancer-spreading risks make it too dangerous, especially for an elective procedure for which there...